Secondaries announced 5.5.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Aldeyra Therapeutics Inc.
Symbol: ALDX
Price: Last trade $9.27
Trade Date: 5/8
Shares: 3 million
Underwriter(s) Cowen & Co., Canaccord Genuity
Co Manager(s) Janney Montgomery Scott, Laidlaw & Co.(UK)
Rating=Subscription Needed

Company: Antares Pharma
Symbol: ATRS
Price: Last trade $2.30
Trade Date: 5/6
Shares: TBD
Underwriter(s) Piper Jaffray
Rating=Subscription Needed